Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
US-Scandinavian Researchers Present DiaGenic's Breast Cancer MDx Prototype at AACR Late-Breaking Sessions
May 1st, 2007
DiaGenic ASA today presented prototypes for its early diagnostic test for breast cancer at the American Association for Cancer Research's special Late-Breaking sessions at the 2007 Annual Meeting. Based on gene expression analysis using peripheral blood as sample material, the DiaGenic test trialed by samples from leading US and Scandinavian breast cancer specialists demonstrated high sensitivity and specificity on both prototypes. "Blood based tests will in the future be very valuable tools alongside the new imaging technologies like MRI for improved diagnosis of breast cancer. Because of its patient-friendliness, DiaGenic's approach is extremely promising and I now...
Source: Cancer Weekly (2007-05-01)
|
